Page last updated: 2024-12-04

beta-amanitin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-amanitin: RN given refers to L-Asp [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2276
CHEMBL ID1978871
SCHEMBL ID3505949
MeSH IDM0141072

Synonyms (13)

Synonym
nsc-627727
.beta.-amanitin
nsc627727
NCI60_008881
beta-amanitin
beta-amanitin from amanita phalloides, ~90% (hplc)
21150-22-1
SCHEMBL3505949
CHEMBL1978871
J-013881
IEQCUEXVAPAFMQ-UHFFFAOYSA-N
2-[34-butan-2-yl-13-(3,4-dihydroxybutan-2-yl)-8,22-dihydroxy-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid
beta -amanitin

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Twice as toxic as free alpha-amanitin."( Strongly enhanced toxicity of the mushroom toxin alpha-amanitin by an amatoxin-specific Fab or monoclonal antibody.
Derenzini, M; Faulstich, H; Kirchner, K, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (10.34)18.7374
1990's4 (13.79)18.2507
2000's5 (17.24)29.6817
2010's9 (31.03)24.3611
2020's8 (27.59)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.99 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (6.90%)4.05%
Observational0 (0.00%)0.25%
Other27 (93.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]